One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The health and wellbeing of the African diaspora
doi : 10.1016/S2213-8587(22)00255-8
Volume 10, Issue 10, October 2022, Page 681
Central diabetes insipidus from a patient's perspective
Mark E Molitch a
Fetal growth patterns as early markers of fetal programming
doi : 10.1016/S2213-8587(22)00250-9
Volume 10, Issue 10, October 2022, Pages 683-684
Improving HbA1c levels with advanced hybrid closed-loop therapy
Peter G Jacobs a
PCSK9 inhibition in children with familial hypercholesterolaemia
Robert A Hegele a
Growing global burden of type 1 diabetes needs multitiered precision public health interventions
doi : 10.1016/S2213-8587(22)00257-1
Volume 10, Issue 10, October 2022, Pages 688-689
Heart failure: now centre-stage in diabetes
John J V McMurray a, Naveed Sattar a
Ultra-processed food: a global problem requiring a global solution
Samuel J Dicken a, Rachel L Batterham a b c
Insulin pricing in the USA: the saga continues
doi : 10.1016/S2213-8587(22)00251-0
Volume 10, Issue 10, October 2022, Page 695
Adverse childhood experiences in diabetes care
doi : 10.1016/S2213-8587(22)00256-X
Volume 10, Issue 10, October 2022, Pages 695-696
Paisan Ruamviboonsuk: saving sight in Thailand
doi : 10.1016/S2213-8587(22)00217-0
Volume 10, Issue 10, October 2022, Page 697
Stigma in type 1 diabetes: a global problem
doi : 10.1016/S2213-8587(22)00242-X
Volume 10, Issue 10, October 2022, Pages 698-699
Correction to Lancet Diabetes Endocrinol 2021; 9: 743–54
doi : 10.1016/S2213-8587(22)00223-6
Volume 10, Issue 10, October 2022, Page e10
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey
Cihan Atila MD a b, Paul Benjamin Loughrey MD c d, Aoife Garrahy MD e, Bettina Winzeler MD a b, Julie Refardt MD a b, Patricia Gildroy PhD f, Malak Hamza MD g, Aparna Pal PhD e, Prof Joseph G Verbalis MD n, Prof Christopher J Thompson MD i j, Lars G Hemkens MD b o p q, Prof Steven J Hunter MD c, Prof Mark Sherlock PhD i j, Prof Miles J Levy MD g, Niki Karavitaki PhD k l m, Prof John Newell-Price PhD h, Prof John A H Wass e, Prof Mirjam Christ-Crain PhD a b
Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study
doi : 10.1016/S2213-8587(22)00215-7
Volume 10, Issue 10, October 2022, Pages 710-719
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study
Prof Pratik Choudhary MBBS a b, Ralf Kolassa MD c, Winfried Keuthage MD d, Jens Kroeger MD e, Prof Charles Thivolet MD f, Prof Mark Evans MD g, Roseline Ré MS h, Simona de Portu PharmD h, Linda Vorrink MS h, John Shin PhD i, Aklilu Habteab PhD j, Javier Castañeda MS j, Julien da Silva MS h, Prof Ohad Cohen MD h, ADAPT study Group â€
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT
Raul D Santos MD a, Andrea Ruzza MD b, Prof G Kees Hovingh MD d, Prof Claudia Stefanutti MD f, Prof François Mach MD g, Olivier S Descamps MD h, Prof Jean Bergeron MD i, Bei Wang PhD c, Andrea Bartuli MD j, Paola Sabrina Buonuomo MD j, Susanne Greber-Platzer MD k, Ilse Luirink MD e, Ajay K Bhatia MD b, Prof Frederick J Raal PhD l, Prof John J P Kastelein MD d, Albert Wiegman MD e, Prof Daniel Gaudet MD m
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study
doi : 10.1016/S2213-8587(22)00218-2
Volume 10, Issue 10, October 2022, Pages 741-760
